Table 4.
Genes | SNPs | Genotype/allele | Long COVID | Genetic models | Unadjusted model | Adjusted model | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No | % | Yes | % | P-value | OR | 95% CI | P-value | aOR | 95% CI | ||||
LZTFL1 | rs10490770 | CC | 0 | 0.00 | 3 | 6.12 | CC vs. TC + TT | 0.999 | NA | NA | - | - | - |
TC | 21 | 9.95 | 5 | 10.20 | TC vs. CC + TT | 0.958 | 1.028 | 0.367-2.877 | - | - | - | ||
TT | 190 | 90.05 | 41 | 83.67 | TT vs. CC + TC | 0.206 | 0.566 | 0.235-1.368 | - | - | - | ||
C | 21 | 4.98 | 11 | 11.22 | CC vs. TC | 0.999 | N/A | N/A | - | - | - | ||
T | 401 | 95.02 | 87 | 88.78 | CC vs. TT | 0.999 | N/A | N/A | - | - | - | ||
TT vs. TC | 0.852 | 1.103 | 0.393-3.097 | - | - | - | |||||||
C vs. T | 0.024 | 2.414 | 1.123-5.191 | 0.001 | 4.416 | 1.900-10.267 | |||||||
LZTFL1 | rs11385942 | AA/AA | 190 | 90.05 | 41 | 83.67 | AA/AA vs. AA/dupA + dupA/dupA | 0.202 | 0.563 | 0.233-1.360 | - | - | - |
AA/dupA | 21 | 9.95 | 5 | 10.20 | AA/dupA vs. AA/AA + dupA/dupA | 0.950 | 1.034 | 0.369-2.892 | - | - | - | ||
dupA/dupA | 0 | 0.00 | 3 | 6.12 | dupA/dupA vs. AA/AA + AA/dupA | 0.999 | N/A | N/A | - | - | - | ||
AA | 401 | 95.02 | 87 | 88.78 | AA/AA vs. AA/dupA | 0.844 | 1.109 | 0.395-3.113 | - | - | - | ||
dupA | 21 | 4.98 | 11 | 11.22 | AA/AA vs. dupA/ dupA | 0.999 | N/A | N/A | - | - | - | ||
AA/AA | AA/dupA vs. dupA/dupA | 0.999 | N/A | N/A | - | - | - | ||||||
dupA vs. AA | 0.025 | 2.402 | 1.117-5.165 | 0.001 | 4.416 | 1.9-10.267 | |||||||
NADSYN1 | rs12785878 | GG | 106 | 50.24 | 25 | 51.02 | GG vs. GT + TT | 0.945 | 1.022 | 0.549-1.903 | - | - | - |
GT | 88 | 41.71 | 15 | 30.61 | GT vs. GG + TT | 0.162 | 0.622 | 0.319-1.210 | - | - | - | ||
TT | 17 | 8.06 | 9 | 18.37 | TT vs. GT + GG | 0.034 | 2.581 | 1.074-6.202 | 0.039 | 2.612 | 1.048-6.510 | ||
G | 300 | 71.09 | 65 | 66.33 | GG vs. GT | 0.377 | 1.371 | 0.681-2.759 | - | - | - | ||
T | 122 | 28.91 | 33 | 33.67 | GG vs. TT | 0.081 | 0.441 | 0.176-1.105 | - | - | - | ||
TT vs. GT | 0.023 | 3.106 | 1.17-8.242 | 0.026 | 3.727 | 1.171-11.860 | |||||||
G vs. T | 0.354 | 0.801 | 0.501-1.280 | - | - | - | |||||||
PLXNA4 | rs1424597 | AA | 7 | 3.32 | 5 | 10.20 | AA vs. GA + GG | 0.048 | 3.328 | 1.009-10.971 | - | - | - |
GA | 66 | 31.28 | 12 | 24.49 | GA vs. AA + GG | 0.361 | 0.717 | 0.352-1.464 | - | - | - | ||
GG | 138 | 65.40 | 32 | 65.31 | GG vs. AA + GA | 0.972 | 0.989 | 0.515-1.899 | - | - | - | ||
A | 80 | 18.96 | 22 | 22.45 | AA vs. GA | 0.039 | 3.929 | 1.068-14.445 | 0.026 | 5.573 | 1.223-25.403 | ||
G | 342 | 81.04 | 76 | 77.55 | AA vs. GG | 0.067 | 3.103 | 0.925-10.408 | - | - | - | ||
GG vs. GA | 0.524 | 0.79 | 0.382-1.631 | - | - | - | |||||||
A vs. G | 0.434 | 1.237 | 0.726-2.109 | - | - | - | |||||||
LZTFL1 | rs17713054 | AA | 0 | 0.00 | 3 | 6.12 | AA vs. GA + GG | 0.999 | N/A | N/A | - | - | - |
GA | 21 | 9.95 | 5 | 10.20 | GA vs. AA + GG | 0.950 | 1.034 | 0.369-2.892 | - | - | - | ||
GG | 190 | 90.05 | 41 | 83.67 | GG vs. AA + GA | 0.202 | 0.563 | 0.233-1.360 | - | - | - | ||
A | 21 | 4.98 | 11 | 11.22 | AA vs. GA | 0.999 | N/A | N/A | - | - | - | ||
G | 401 | 95.02 | 87 | 88.78 | AA vs. GG | 0.999 | N/A | N/A | - | - | - | ||
GA vs.GG | 0.844 | 1.109 | 0.395-3.113 | - | - | - | |||||||
A vs. G | 0.024 | 2.414 | 1.123-5.191 | 0.001 | 4.416 | 1.900-10.267 | |||||||
IL10 | rs1800896 | CC | 0 | 0.00 | 0 | 0.00 | CC vs. TC + TT | 0 | 0.231 | N/A | - | - | - |
TC | 16 | 7.58 | 9 | 18.37 | TC vs. CC + TT | 0.025 | 2.756 | 1.138-6.676 | 0.035 | 2.984 | 1.078-8.258 | ||
TT | 195 | 92.42 | 40 | 81.63 | TT vs. CC + TC | 0.025 | 0.363 | 0.150-0.879 | 0.035 | 0.335 | 0.121-0.927 | ||
C | 16 | 3.79 | 9 | 9.18 | CC vs. TC | 0 | 0.231 | N/A | - | - | - | ||
T | 406 | 96.21 | 89 | 90.82 | CC vs. TT | 0 | 0.231 | N/A | - | - | - | ||
TC vs. TT | 0.025 | 2.756 | 1.138-6.676 | 0.035 | 2.984 | 1.078-8.258 | |||||||
C vs. T | 0.029 | 2.566 | 1.099-5.993 | 0.042 | 2.708 | 1.038-7.062 | |||||||
ACE2 | rs2285666 | CC | 71 | 33.65 | 9 | 18.37 | CC vs. CT + TT | 0.040 | 0.444 | 0.204-0.965 | 0.043 | 0.44 | 0.199-0.975 |
CT | 54 | 25.59 | 16 | 32.65 | CT vs. CC + TT | 0.317 | 1.41 | 0.72-2.761 | - | - | - | ||
TT | 86 | 40.76 | 24 | 48.98 | TT vs. CC + CT | 0.295 | 1.395 | 0.748-2.604 | - | - | - | ||
C | 196 | 46.45 | 34 | 34.69 | CC vs. CT | 0.062 | 0.428 | 0.176-1.042 | - | - | - | ||
T | 226 | 53.55 | 64 | 65.31 | CC vs. TT | 0.062 | 0.454 | 0.198-1.040 | - | - | - | ||
CT vs. TT | 0.870 | 1.062 | 0.518-2.178 | - | - | - | |||||||
T vs. C | 0.036 | 0.613 | 0.388-0.968 | 0.038 | 0.648 | 0.290-0.637 | |||||||
PEDS1 | rs6020298 | AA | 47 | 22.27 | 6 | 12.24 | AA vs. GA + GG | 0.123 | 0.487 | 0.195-1.214 | - | - | - |
GA | 112 | 53.08 | 23 | 46.94 | GA vs. AA + GG | 0.439 | 0.782 | 0.419-1.458 | - | - | - | ||
GG | 52 | 24.64 | 20 | 40.82 | GG vs. AA + GA | 0.024 | 2.109 | 1.101-4.040 | 0.037 | 2.062 | 1.046-4.066 | ||
A | 206 | 48.82 | 35 | 35.71 | AA vs. GA | 0.332 | 0.622 | 0.238-1.625 | - | - | - | ||
G | 216 | 51.18 | 63 | 64.29 | AA vs. GG | 0.030 | 0.332 | 0.123-0.897 | 0.050 | 0.347 | 0.120-0.998 | ||
GA vs. GG | 0.072 | 0.534 | 0.270-1.058 | - | - | - | |||||||
G vs. A | 0.020 | 1.717 | 1.089-2.706 | 0.046 | 1.608 | 1.008-2.565 | |||||||
IL10RB | rs8178562 | AA | 32 | 15.17 | 10 | 20.41 | AA vs. GA + GG | 0.371 | 1.434 | 0.651-3.160 | - | - | - |
GA | 93 | 44.08 | 27 | 55.10 | GA vs. AA + GG | 0.165 | 1.557 | 0.833-2.909 | - | - | - | ||
GG | 86 | 40.76 | 12 | 24.49 | GG vs. AA + GA | 0.037 | 0.471 | 0.233-0.956 | 0.033 | 0.456 | 0.221-0.940 | ||
A | 157 | 37.20 | 47 | 47.96 | AA vs. GA | 0.862 | 1.076 | 0.470-2.467 | - | - | - | ||
G | 265 | 62.80 | 51 | 52.04 | AA vs. GG | 0.090 | 2.24 | 0.882-5.689 | - | - | - | ||
GA vs. GG | 0.052 | 2.081 | 0.992-4.363 | - | - | - | |||||||
A vs. G | 0.050 | 1.556 | 0.999-2.422 | - | - | - |
P-values marked with bold indicate statistically significant associations between genetic polymorphisms and susceptibility to Long COVID.
OR was adjusted for age, BMI, and comorbidities.
Abbreviations: ACE2, angiotensin converting enzyme-2; CI, confidence interval; COVID-19, coronavirus disease 2019; IL10, interleukin-10; IL10RB, interleukin-10 receptor subunit beta; LZTFL1, leucine zipper transcription factor like-1; N/A, not available; NADSYN1, NAD synthetase-1; OR, odds ratio; PEDS1, plasmanylethanolamine desaturase-1; PLXNA4, plexin A4; SNP, single nucleotide polymorphism.